Evidence map›Paper›PMID 42797169›Full record

ArticlePolymers2026

High-Density, Extrudable Collagen Types I and II Microfiber-Based Inks for Tissue Engineering Applications.

Kevin Capariño, Shu-Tung Li

Abstract read
In one paragraph

Article in Polymers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kevin CapariñoShu-Tung and Alice Li Foundation, Laboratory for Tissue Engineering Research, Oakland, NJ 07436, USA.
Shu-Tung LiShu-Tung and Alice Li Foundation, Laboratory for Tissue Engineering Research, Oakland, NJ 07436, USA.ORCID 0000-0001-8585-431X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extrusion-based 3D-printing of collagen currently relies almost exclusively on solubilizing collagen, restricting ink formulations to low-density hydrogels that typically contain less than 1% (10 mg/mL) collagen. This low collagen content results in poor mechanical properties, which limit print stability at room temperature and pose significant challenges for engineering scaffolds for high load-bearing tissues. Here, we introduce a method that leverages collagen's electrostatic properties to generate extrudable inks composed of intact, insoluble collagen across a broad range of densities, including 20% (200 mg/mL). These inks preserve native collagen fiber architecture, can be prepared at neutral pH, and allow for room-temperature printing without additional stabilization procedures. Our approach is applicable to both type I collagen and type II collagen, enabling scaffolds to be fabricated with collagen in a form and at contents that more closely reflect those of a variety of tissues. By overcoming limitations associated with soluble, atelocollagen hydrogels, these high-density, insoluble collagen microfiber-based inks provide a new platform for developing physiologically relevant scaffolds for tissue-engineering applications.

Indexed as

3D bioprintingbiomaterialscell compatibilitycollagen-based inkcollagen scaffoldsextracellular matrixmechanical propertiestissue engineeringtype I collagentype II collagen

Identifiers

PMID42797169
PMCPMC13611240

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.